NEW BRUNSWICK, N.J.,
June 21, 2016 /PRNewswire/
-- Johnson & Johnson (NYSE: JNJ) will host a conference
call for investors at 8:30 a.m. (Eastern
Time) on Tuesday, July
19th, to review second-quarter results.
Alex Gorsky, Chairman and Chief
Executive Officer, Dominic Caruso,
Executive Vice President, Chief Financial Officer and Louise Mehrotra, Vice President, Investor
Relations, will host the call.
Investors and other interested parties may access the conference
call in the following ways:
- The webcast is accessible at Johnson & Johnson's website:
www.investor.jnj.com. A webcast and podcast replay will be
available approximately one hour after the conference call
concludes.
- By telephone: for both "listen-only" participants and
those financial analysts who wish to take part in the
question-and-answer portion of the call, the telephone dial-in
number in the U.S. is 877-869-3847. For participants outside
the U.S., the dial-in number is 201-689-8261.
- A replay of the conference call will be available until
approximately 12:00 a.m. on
July 27, 2016. The replay dial-in
number for U.S. participants is 877-660-6853. For participants
outside the U.S., the replay dial-in number is 201-612-7415. The
replay conference ID number for all callers is 13639782.
- Presentation materials will be available on
www.investor.jnj.com.
- The press release will be available at approximately
6:45 a.m. (Eastern Time) the morning
of the conference call.
About Johnson & Johnson
Caring for the world, one person at a time, inspires and unites
the people of Johnson & Johnson. We embrace research and
science - bringing innovative ideas, products and services to
advance the health and well-being of people. Our approximately
127,500 employees at more than 250 Johnson & Johnson operating
companies work with partners in health care to touch the lives of
over a billion people every day, throughout the world.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/johnson--johnson-to-host-investor-conference-call-on-second-quarter-results-300288122.html
SOURCE Johnson & Johnson